Status:
COMPLETED
Fatigue Reduction Diet in Lymphoma Survivors
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Lymphoma, Large B-Cell, Diffuse
Fatigue
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The purpose of this small preliminary study is to gather preliminary data to support a large randomized controlled trial of a fatigue reduction diet intervention among diffuse-large B-cell lymphoma (D...
Detailed Description
Fatigue is highly prevalent in survivors of diffuse-large B-cell lymphoma (DLBCL). Fatigue has been linked to chronic inflammation, and diets high in antioxidant nutrients (diet rich in fruit, vegetab...
Eligibility Criteria
Inclusion
- Adult patients (18+) with Diffuse large B-cell lymphoma (DLBCL) who have completed their upfront chemoimmunotherapy, and remained in remission for 2 years prior to enrollment
Exclusion
- Unable to provide consent or speak English
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 24 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05327725
Start Date
March 15 2021
End Date
September 24 2021
Last Update
September 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210